Sanofi snaps up Origimm for early-phase acne vaccine, opening new front in mRNA strategy
Sanofi snaps up Origimm for early-phase acne vaccine, opening new [...]
Mei, with Bayer and Gilead in its sights, posts pivotal data on blood cancer prospect
Mei, with Bayer and Gilead in its sights, posts pivotal [...]
GlaxoSmithKline poaches Pfizer vax leader Dormitzer after hemorrhaging vaccine R&D talent
GlaxoSmithKline poaches Pfizer vax leader Dormitzer after hemorrhaging vaccine R&D [...]
RAGE against diabetes complications: Novel drug tamps down tissue damage in mice
RAGE against diabetes complications: Novel drug tamps down tissue damage [...]
Could common antihistamines be the key to boosting immuno-oncology treatments?
Could common antihistamines be the key to boosting immuno-oncology treatments? [...]
Turnstone teams up with Moffitt to race TIL cell therapies into the clinic
Turnstone teams up with Moffitt to race TIL cell therapies [...]
FDA halts phase 1b Kura Oncology trial in acute myeloid leukemia following patient death
FDA halts phase 1b Kura Oncology trial in acute myeloid [...]
Chasing Regeneron, Pfizer posts data on $250M cardiovascular bet
Chasing Regeneron, Pfizer posts data on $250M cardiovascular bet ntaylor [...]
Kymera’s first-in-class protein degrader shows potential to boost cancer immunotherapy
Kymera’s first-in-class protein degrader shows potential to boost cancer immunotherapy [...]
Acorda CMO hits the exit, landing Pharnext job with oversight of phase 3 neurological disorder trial
Acorda CMO hits the exit, landing Pharnext job with oversight [...]